Myeloablative conditioning with intravenous busulphan in a single daily dose and fludarabine for HLA-identical sibling allogeneic HSCT in myeloid malignancies

P976

  • de la Serna, J.
  • Bermudez, A.
  • Sanz, J.
  • Caballero, D.
  • Serrano, D.
  • de la Camara, R.
  • Vallejo, C.
  • Moraleda, J.
  • Noblejas, Garcia A.
  • Cabrero, M.
  • Lahuerta, J. J.
  • Iriondo, A.
  • Benlloch, L.
  • on behalf of GETH, Sanz G.
Bone Marrow Transplantation 46:p S294, April 2011.
Copyright © 2011 Nature Publishing Group